no edit summary
Line 1: Line 1: −
[[Image:Soft Tissue Sx 20a|centre|500px]]
+
{{Template:Manson
 +
|book = Small Animal Soft Tissue Surgery Q&A}}
 +
 
 +
 
 +
[[Image:Soft Tissue Sx 20a.jpg|centre|500px]]
 
<br>
 
<br>
[[Image:Soft Tissue Sx 20b|centre|500px]]
+
[[Image:Soft Tissue Sx 20b.jpg|centre|500px]]
 
<br>
 
<br>
[[Image:Soft Tissue Sx 20c|centre|500px]]
+
[[Image:Soft Tissue Sx 20c.jpg|centre|500px]]
    
<br />
 
<br />
Line 15: Line 19:  
|a1=
 
|a1=
 
Extrahepatic portosystemic shunt.
 
Extrahepatic portosystemic shunt.
|l1=
+
|l1=Portosystemic Shunt
 
|q2=Describe the surgical therapy.
 
|q2=Describe the surgical therapy.
 
|a2=
 
|a2=
Line 25: Line 29:     
More recently, reports of shunt occlusion using an ameroid ring have shown good results with limited morbidity and mortality.
 
More recently, reports of shunt occlusion using an ameroid ring have shown good results with limited morbidity and mortality.
|l2=
+
|l2=Portosystemic Shunt#Treatment
 
|q3=What is the prognosis following surgery?
 
|q3=What is the prognosis following surgery?
 
|a3=
 
|a3=
Line 31: Line 35:     
Persistence or relapse of clinical signs after initial improvement is common and is caused in some cases by development of multiple acquired portosystemic shunts after surgery.
 
Persistence or relapse of clinical signs after initial improvement is common and is caused in some cases by development of multiple acquired portosystemic shunts after surgery.
|l3=
+
|l3=Portosystemic Shunt#Prognosis
 
</FlashCard>
 
</FlashCard>
  
Author, Donkey, Bureaucrats, Administrators
53,803

edits